Intracellular Targeting Mechanisms by Antimicrobial Peptides
暂无分享,去创建一个
[1] P. Tempst,et al. Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. , 1994, Biochemical and biophysical research communications.
[2] T. Sorsa,et al. The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. , 1990, Archives of oral biology.
[3] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[4] Lin Yang. Neutron off-plane scattering of aligned membranes , 1998 .
[5] S H White,et al. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. , 1997, Biophysical journal.
[6] Wayne L. Smith,et al. Purification, primary structures, and antibacterial activities of β-defensins, a new family of antimicrobial peptides from bovine neutrophils. , 1996, The Journal of Biological Chemistry.
[7] R. Hancock,et al. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria , 2007, Expert review of anti-infective therapy.
[8] D. Andersson,et al. Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2 , 2008, Antimicrobial Agents and Chemotherapy.
[9] J. Grogan,et al. Salivary histatin 5 is a potent competitive inhibitor of the cysteine proteinase clostripain , 2001, FEBS letters.
[10] R. Nagaraj,et al. Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13‐residue peptide indolicidin , 1996, FEBS letters.
[11] C. Griesinger,et al. Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics. , 1997, European journal of biochemistry.
[12] V. Saba,et al. Neutralization of Endotoxin In Vitro and In Vivo by BAC7(1-35), a Proline-Rich Antibacterial Peptide , 2003, Shock.
[13] Ayyalusamy Ramamoorthy,et al. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. , 2006, Biochimica et biophysica acta.
[14] J. Helterbrand,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .
[15] C. Esmon. Regulation of blood coagulation. , 2000, Biochimica et biophysica acta.
[16] Y. Shai,et al. Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.
[17] R. Farías,et al. The peptide antibiotic microcin 25 is imported through the TonB pathway and the SbmA protein , 1995, Journal of bacteriology.
[18] E. Breukink,et al. Lipid II as a target for antibiotics , 2006, Nature Reviews Drug Discovery.
[19] V. Iacono,et al. Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans , 1984, Infection and immunity.
[20] J. Wiesner,et al. Insect antimicrobial peptides show potentiating functional interactions against Gram-negative bacteria , 2015, Proceedings of the Royal Society B: Biological Sciences.
[21] R. Lehrer,et al. Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils , 1993, Infection and immunity.
[22] K. Entian,et al. Two Different Lantibiotic-Like Peptides Originate from the Ericin Gene Cluster of Bacillus subtilis A1/3 , 2002, Journal of bacteriology.
[23] A. Pugsley,et al. Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. , 1986, Journal of general microbiology.
[24] T. Meinnel,et al. The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. , 2014, Chemistry & biology.
[25] B. Ho,et al. Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. , 2000, European journal of biochemistry.
[26] M. Phansalkar,et al. Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. , 1992, The Journal of antibiotics.
[27] R. Hoffmann,et al. Rational Design of Oncocin Derivatives with Superior Protease Stabilities and Antibacterial Activities Based on the High‐Resolution Structure of the Oncocin‐DnaK Complex , 2011, Chembiochem : a European journal of chemical biology.
[28] Wei-Ting Huang,et al. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA , 2005, Nucleic acids research.
[29] S. Sekaran,et al. In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin , 2015, Scientific Reports.
[30] C. Gaggero,et al. Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli , 1990, Journal of bacteriology.
[31] Alan J. Waring,et al. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.
[32] R. Nagaraj,et al. Indolicidin, a 13-residue basic antimicrobial peptide rich in tryptophan and proline, interacts with Ca(2+)-calmodulin. , 2003, Biochemical and biophysical research communications.
[33] C. Raetz,et al. Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.
[34] R. Hancock,et al. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification , 1994, Antimicrobial Agents and Chemotherapy.
[35] T. Miyata,et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. , 1988, The Journal of biological chemistry.
[36] W. Foss,et al. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. , 1998, The Journal of clinical investigation.
[37] Ashok Kumar,et al. Tumor Necrosis Factor-α Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells* , 2003, Journal of Biological Chemistry.
[38] S. Lovas,et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.
[39] Y. Pommier,et al. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites , 2006, Nucleic acids research.
[40] H. Vogel,et al. The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.
[41] J. Potempa,et al. Salivary Histatin 5 Is an Inhibitor of Both Host and Bacterial Enzymes Implicated in Periodontal Disease , 2001, Infection and Immunity.
[42] C. Walsh,et al. Thiazole and oxazole peptides: biosynthesis and molecular machinery. , 1999, Natural product reports.
[43] W. Vollmer,et al. Morphogenesis of Escherichia coli. , 2001, Current opinion in microbiology.
[44] R. Hancock. Peptide antibiotics , 1997, The Lancet.
[45] O. Kuipers,et al. An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II , 2006, Science.
[46] Michelle D. Wang,et al. Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25. , 2004, Molecular cell.
[47] S. Lovas,et al. Interaction between heat shock proteins and antimicrobial peptides. , 2000, Biochemistry.
[48] Yi-Wen Chen,et al. Systematic Analysis of Intracellular-targeting Antimicrobial Peptides, Bactenecin 7, Hybrid of Pleurocidin and Dermaseptin, Proline–Arginine-rich Peptide, and Lactoferricin B, by Using Escherichia coli Proteome Microarrays* , 2016, Molecular & Cellular Proteomics.
[49] P. Tempst,et al. Apidaecins: antibacterial peptides from honeybees. , 1989, The EMBO journal.
[50] L. Becucci,et al. Dermcidin, an anionic antimicrobial peptide: influence of lipid charge, pH and Zn2+ on its interaction with a biomimetic membrane. , 2014, Soft matter.
[51] M. Selsted,et al. Synthesis and characterization of indolicidin, a tryptophan-rich antimicrobial peptide from bovine neutrophils * , 2009 .
[52] H. Sahl,et al. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase , 1987, Journal of bacteriology.
[53] S. Levitz,et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. , 1988, The Journal of biological chemistry.
[54] P. Yu,et al. Mechanisms of action of ostrich β‐defensins against Escherichia coli , 2007 .
[55] B. Schonwetter,et al. Epithelial antibiotics induced at sites of inflammation , 1995, Science.
[56] C. Subbalakshmi,et al. Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.
[57] R. Hancock,et al. Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.
[58] A. Mor,et al. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. , 1995, Annual review of microbiology.
[59] Y. Tu,et al. Identification of Lactoferricin B Intracellular Targets Using an Escherichia coli Proteome Chip , 2011, PloS one.
[60] R. Kaptein,et al. The nisin–lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics , 2004, Nature Structural &Molecular Biology.
[61] G. Wider,et al. Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis* , 2014, The Journal of Biological Chemistry.
[62] M. Benincasa,et al. Dual mode of action of Bac7, a proline-rich antibacterial peptide. , 2006, Biochimica et biophysica acta.
[63] Ellis Rj. The molecular chaperone concept. , 1990 .
[64] S. Gordon,et al. The potential for Toll‐like receptors to collaborate with other innate immune receptors , 2004, Immunology.
[65] S. Sekaran,et al. Transcriptome analysis of Streptococcus pneumoniae treated with the designed antimicrobial peptides, DM3 , 2016, Scientific Reports.
[66] Chong Li,et al. Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II , 2010, FEBS letters.
[67] R. Hancock,et al. Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.
[68] Patchen Dellinger,et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[69] R. Hancock,et al. Antiendotoxin activity of cationic peptide antimicrobial agents , 1996, Infection and immunity.
[70] Elizabeth M. Nolan,et al. Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5. , 2015, Biochemistry.
[71] A. L. Koch. Bacterial Wall as Target for Attack , 2003, Clinical Microbiology Reviews.
[72] A. Bottrill,et al. The action of the bacterial toxin, microcin B17, on DNA gyrase. , 2007, Biochimie.
[73] O. Franco,et al. Deciphering the Magainin Resistance Process of Escherichia coli Strains in Light of the Cytosolic Proteome , 2012, Antimicrobial Agents and Chemotherapy.
[74] R. Lanot,et al. Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. , 1994, The Biochemical journal.
[75] M. Selsted,et al. Anti‐HIV‐1 activity of indolicidin, an antimicrobial peptide from neutrophils , 1998, Journal of leukocyte biology.
[76] Takanori Nakamura,et al. Tachyplesin, a Class of Antimicrobial Peptide from the Hemocytes of the Horseshoe Crab (Tach ypleus tridentatus) , 1988 .
[77] Y. Shai,et al. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. , 1998, Biopolymers.
[78] R. Farías,et al. Microcin 25, a novel antimicrobial peptide produced by Escherichia coli , 1992, Journal of bacteriology.
[79] T. Ganz,et al. Antimicrobial peptides of leukocytes , 1997, Current opinion in hematology.
[80] J. V. D. van der Meer,et al. Update on meningococcal disease with emphasis on pathogenesis and clinical management. , 2000, Clinical microbiology reviews.
[81] C. Walsh,et al. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. , 2001, Journal of molecular biology.
[82] R. Hancock,et al. Sublethal Concentrations of Pleurocidin-Derived Antimicrobial Peptides Inhibit Macromolecular Synthesis in Escherichia coli , 2002, Antimicrobial Agents and Chemotherapy.
[83] J. Lutkenhaus. Regulation of cell division in E. coli. , 1990, Trends in genetics : TIG.
[84] J. Kobayashi,et al. Cloning of mRNA Sequences for Two Antibacterial Peptides in a Hemipteran Insect, Riptortus clavatus , 1996, Zoological science.
[85] Shamala Devi Sekaran,et al. Activity of Novel Synthetic Peptides against Candida albicans , 2015, Scientific Reports.
[86] Gao Shuang,et al. Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation , 2016 .
[87] Astrid Gräslund,et al. Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.
[88] R. Ellis. The molecular chaperone concept. , 1990, Seminars in cell biology.
[89] F. Oppenheim,et al. Structural Relationship Between Human Salivary Histatins , 1990, Journal of dental research.
[90] R. Lehrer,et al. eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes , 1992, Infection and immunity.
[91] S. Sekaran,et al. In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin , 2015, Scientific Reports.
[92] Arwyn Tomos Jones,et al. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides , 2007, Journal of cellular and molecular medicine.
[93] R. M. Pino,et al. Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis , 2018 .
[94] Bingyun Li,et al. Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus , 2012, Antimicrobial Agents and Chemotherapy.
[95] N. Fukuishi,et al. Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells , 2007, Inflammation Research.
[96] Wayne L. Smith,et al. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.
[97] R. Hancock,et al. Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.
[98] H. Sahl,et al. Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. , 1981, Journal of general microbiology.
[99] P. Yu,et al. Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils. , 2003, Biochemical and biophysical research communications.
[100] S. Chatterjee,et al. Indolicidin Targets Duplex DNA: Structural and Mechanistic Insight through a Combination of Spectroscopy and Microscopy , 2014, ChemMedChem.
[101] A. Bayer,et al. Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus , 1992, Antimicrobial Agents and Chemotherapy.
[102] H. Vogel,et al. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[103] Andreas Peschel,et al. How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.
[104] H. G. Boman,et al. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.
[105] Olivier Taboureau,et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus , 2005, Nature.
[106] S. Nechaev,et al. Mutations of Bacterial RNA Polymerase Leading to Resistance to Microcin J25* , 2002, The Journal of Biological Chemistry.
[107] Ya-li Tang,et al. The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2 , 2013, Journal of Microbiology.
[108] I. C. Almeida,et al. Ixodidin, a novel antimicrobial peptide from the hemocytes of the cattle tick Boophilus microplus with inhibitory activity against serine proteinases , 2006, Peptides.
[109] T. Lüders,et al. Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.). , 2003, Biochimica et biophysica acta.
[110] R. Hoffmann,et al. Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. , 2010, Journal of medicinal chemistry.
[111] P. Tempst,et al. Apidaecin multipeptide precursor structure: a putative mechanism for amplification of the insect antibacterial response. , 1993, The EMBO journal.
[112] O. Kohashi,et al. Morphology of defensin-treated Staphylococcus aureus , 1995, Infection and immunity.
[113] V. Mutt,et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. , 1991, European journal of biochemistry.
[114] H. Sahl,et al. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential , 1996, Infection and immunity.
[115] M. Ghannoum,et al. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro , 1993, Antimicrobial Agents and Chemotherapy.
[116] J. Nakayama,et al. Peptide-Lipid Huge Toroidal Pore, a New Antimicrobial Mechanism Mediated by a Lactococcal Bacteriocin, Lacticin Q , 2009, Antimicrobial Agents and Chemotherapy.
[117] H. Tani,et al. Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. , 1991, Biochemical and biophysical research communications.
[118] P. Koski,et al. Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane , 1988, Infection and immunity.
[119] A. Bayer,et al. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein , 1992, Infection and immunity.
[120] T. Ganz,et al. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae , 2004, BMC infectious diseases.
[121] M. Edgerton,et al. How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5 , 2014, Eukaryotic Cell.
[122] Y. Shai,et al. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. , 1995, Biochemistry.
[123] M. Zasloff. Innate immunity, antimicrobial peptides, and protection of the oral cavity , 2002, The Lancet.
[124] R. Hancock,et al. The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa , 1994, Molecular microbiology.
[125] G. Diamond,et al. Isolation and Characterization of Pleurocidin, an Antimicrobial Peptide in the Skin Secretions of Winter Flounder* , 1997, The Journal of Biological Chemistry.
[126] J. Solbiati,et al. Genetic analysis of plasmid determinants for microcin J25 production and immunity , 1996, Journal of bacteriology.
[127] D. Phoenix,et al. Anionic antimicrobial peptides from eukaryotic organisms. , 2009, Current protein & peptide science.
[128] M. Benincasa,et al. Role of the Escherichia coli SbmA in the antimicrobial activity of proline‐rich peptides , 2007, Molecular microbiology.
[129] R. Kolter,et al. The DNA replication inhibitor microcin B17 is a forty‐three‐amino‐acid protein containing sixty percent glycine , 1986, Proteins.
[130] G. Montelione,et al. Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot. , 2003, Journal of the American Chemical Society.
[131] M. Björklund,et al. Streptococcus mutans, Caries and Simulation Models , 2010, Nutrients.
[132] Shamala Devi Sekaran,et al. Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae , 2015, PloS one.
[133] F. S. Hsiao,et al. The proteome targets of intracellular targeting antimicrobial peptides , 2016, Proteomics.
[134] L. Yang,et al. Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.
[135] T. Kaczorowski,et al. Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant , 1999, Journal of applied microbiology.
[136] V. Smith,et al. Purification and characterization of a proline-rich antibacterial peptide, with sequence similarity to bactenecin-7, from the haemocytes of the shore crab, Carcinus maenas. , 1996, European journal of biochemistry.
[137] Y. Sugiura,et al. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. , 1992, Biochemistry.
[138] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[139] R. Hancock,et al. Structure and Mechanism of Action of an Indolicidin Peptide Derivative with Improved Activity against Gram-positive Bacteria* , 2001, The Journal of Biological Chemistry.
[140] William Wiley Navarre,et al. Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.
[141] Yue Sun,et al. Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation , 2015, Mediators of inflammation.
[142] C. Whitfield,et al. Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.
[143] J. Tam,et al. Design of Gram-negative selective antimicrobial peptides. , 2001, Biochemistry.
[144] C. B. Park,et al. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. , 2000, Biochemistry.
[145] H. Erdjument-Bromage,et al. Biodiversity of apidaecin-type peptide antibiotics. Prospects of manipulating the antibacterial spectrum and combating acquired resistance. , 1994, The Journal of biological chemistry.
[146] B. Finlay,et al. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[147] H. Sahl,et al. The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II , 1998, Antimicrobial Agents and Chemotherapy.
[148] Y. Shai,et al. Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .
[149] C. Ross,et al. Identification of a proline‐arginine‐rich antibacterial peptide from neutrophils that is analogous to PR‐39, an antibacterial peptide from the small intestine , 1994, Journal of leukocyte biology.
[150] Wei-fen Li,et al. Apidaecin-type peptides: Biodiversity, structure–function relationships and mode of action , 2006, Peptides.
[151] M. Selsted,et al. Purification and in vitro activities of rabbit platelet microbicidal proteins , 1997, Infection and immunity.
[152] A. Bayer,et al. In Vitro Antibacterial Activities of Platelet Microbicidal Protein and Neutrophil Defensin against Staphylococcus aureus Are Influenced by Antibiotics Differing in Mechanism of Action , 1999, Antimicrobial Agents and Chemotherapy.
[153] Elizabeth M. Nolan,et al. Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus. , 2011, Biochemistry.
[154] Jennifer L. Knight,et al. Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. , 2004, Molecular cell.
[155] H. Sahl,et al. Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies , 2006, Antimicrobial Agents and Chemotherapy.
[156] C. Hernández-Chico,et al. The peptide antibiotic microcin B17 induces double‐strand cleavage of DNA mediated by E. coli DNA gyrase. , 1991, The EMBO journal.
[157] A. Vitiello,et al. Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.
[158] C. B. Park,et al. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[159] T. Ganz,et al. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. , 1989, The Journal of clinical investigation.
[160] S. N. Witt,et al. The insect antimicrobial peptide, l‐pyrrhocoricin, binds to and stimulates the ATPase activity of both wild‐type and lidless DnaK , 2004, FEBS letters.
[161] H. Sahl,et al. Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci , 2010, Infection and Immunity.
[162] Durba Sengupta,et al. Toroidal pores formed by antimicrobial peptides show significant disorder. , 2008, Biochimica et biophysica acta.
[163] C. B. Park,et al. A novel antimicrobial peptide from Bufo bufo gargarizans. , 1996, Biochemical and biophysical research communications.
[164] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[165] Søren Neve,et al. Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II , 2010, Science.
[166] H. Sahl,et al. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. , 1997, European journal of biochemistry.
[167] Elizabeth M. Nolan,et al. A Bacterial Mutant Library as a Tool to Study the Attack of a Defensin Peptide , 2014, Chembiochem : a European journal of chemical biology.
[168] J. Bruenn,et al. Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways , 2000, Antimicrobial Agents and Chemotherapy.
[169] Chien-Sheng Chen,et al. Lactoferricin B Inhibits the Phosphorylation of the Two-Component System Response Regulators BasR and CreB* , 2011, Molecular & Cellular Proteomics.
[170] H. Sahl,et al. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. , 2004, The Journal of antimicrobial chemotherapy.
[171] J. Tagg,et al. Purification and Characterization of Streptin, a Type A1 Lantibiotic Produced by Streptococcus pyogenes , 2003, Applied and Environmental Microbiology.
[172] Randall Todd,et al. Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae — Washoe County, Nevada, 2016 , 2017, MMWR. Morbidity and mortality weekly report.
[173] F. Hartl,et al. DnaK functions as a central hub in the E. coli chaperone network. , 2012, Cell reports.
[174] T. Weiss,et al. Neutron off-plane scattering of aligned membranes. I. Method Of measurement. , 1998, Biophysical journal.
[175] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[176] Satyajit Mayor,et al. Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.
[177] R. Farías,et al. The FhuA protein is involved in microcin 25 uptake , 1993, Journal of bacteriology.
[178] T. Kubo,et al. Purification and characterization of a diptericin homologue from Sarcophaga peregrina (flesh fly). , 1992, The Biochemical journal.
[179] R. P. Ross,et al. Lantibiotics: structure, biosynthesis and mode of action. , 2001, FEMS microbiology reviews.
[180] P. Christen,et al. The Proline-rich Antibacterial Peptide Bac7 Binds to and Inhibits in vitro the Molecular Chaperone DnaK , 2009, International Journal of Peptide Research and Therapeutics.
[181] R. Hancock,et al. The relationship between peptide structure and antibacterial activity , 2003, Peptides.